More COVID-19 Booster Shots to Come from Moderna and J&J

COVID-19 vaccine manufacturers Moderna and Johnson & Johnson (J&J) submitted data demonstrating the efficacy of their COVID-19 booster shots among those ages 18 and older to the United States Food and Drug Administration (FDA). The FDA will review the data at a 2-day meeting beginning October 14.

The Moderna booster shot contains 50% of the first or second dose given in the two-shot series. It is recommended 6 months after the second dose is administered. The J&J booster is the same strength as the initial dose of the one-shot vaccine. The J&J booster may be administered as early as 2 months after the first dose. Click here to read more.